WO2000063225A3 - Macrolide antiinfective agents - Google Patents

Macrolide antiinfective agents Download PDF

Info

Publication number
WO2000063225A3
WO2000063225A3 PCT/US2000/009915 US0009915W WO0063225A3 WO 2000063225 A3 WO2000063225 A3 WO 2000063225A3 US 0009915 W US0009915 W US 0009915W WO 0063225 A3 WO0063225 A3 WO 0063225A3
Authority
WO
WIPO (PCT)
Prior art keywords
substituted
unsubstituted
amino
alkyl
mono
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/009915
Other languages
French (fr)
Other versions
WO2000063225A2 (en
Inventor
Daniel T W Chu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kosan Biosciences Inc
Original Assignee
Kosan Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kosan Biosciences Inc filed Critical Kosan Biosciences Inc
Priority to KR1020017013225A priority Critical patent/KR20020007374A/en
Priority to JP2000612315A priority patent/JP2003523939A/en
Priority to CA002369886A priority patent/CA2369886A1/en
Priority to MXPA01010529A priority patent/MXPA01010529A/en
Priority to NZ514791A priority patent/NZ514791A/en
Priority to BR0010681-0A priority patent/BR0010681A/en
Priority to IL14577600A priority patent/IL145776A0/en
Priority to EP00925966A priority patent/EP1171448A2/en
Priority to AU44578/00A priority patent/AU775637B2/en
Publication of WO2000063225A2 publication Critical patent/WO2000063225A2/en
Publication of WO2000063225A3 publication Critical patent/WO2000063225A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Compounds of formula (1), (2) or (3) or the 10,11-anhydro forms thereof, wherein Ra is H or OH; Rb is H or halogen; Rc is H or a protecting group; Rd is methyl; unsubstituted alkyl(3-10C); substituted alkyl(1-10C); substituted or unsubstituted alkenyl(2-10C) or substituted or unsubstituted alkynyl(2-10C); substituted or unsubstituted aryl(4-14C); substituted or unsubstituted arylalkyl(5-20C); substituted or unsubstituted arylalkenyl(5-20C); substituted or unsubstituted arylalkynyl(5-20C); substituted or unsubstituted amidoarylalkyl(5-20C); substituted or unsubstituted amidoarylalkenyl(5-20C); or substituted or unsubstituted amidoarylalkynyl(5-20C); Re is H or a protecting group or is mono- or disubstituted amino carbonyl; Rf is H; substituted or unsubstituted alkyl(1-10C), substituted or unsubstituted alkenyl(1-10C); substituted or unsubstituted alkynyl(1-10C); substituted or unsubstituted aryl(4-14C); substituted or unsubstituted arylalkyl(5-20C); or -ORf may be replaced by -H; one of Z and Y is H and the other is OH or protected OH, or is amino, mono- or dialkyl-amino, protected amino, or an aminoheterocycle or Z and Y together are =O, =NOH or a derivatized oxime; including any pharmaceutically acceptable salts thereof and any stereoisomeric forms and mixtures of stereoisomeric forms thereof, are antimicrobial agents.
PCT/US2000/009915 1999-04-16 2000-04-14 Macrolide antiinfective agents Ceased WO2000063225A2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
KR1020017013225A KR20020007374A (en) 1999-04-16 2000-04-14 Macrolide antiinfective agents
JP2000612315A JP2003523939A (en) 1999-04-16 2000-04-14 Macrolide anti-infectives
CA002369886A CA2369886A1 (en) 1999-04-16 2000-04-14 Macrolide antiinfective agents
MXPA01010529A MXPA01010529A (en) 1999-04-16 2000-04-14 Macrolide antiinfective agents.
NZ514791A NZ514791A (en) 1999-04-16 2000-04-14 Erythromycin derivatives useful as antibiotics
BR0010681-0A BR0010681A (en) 1999-04-16 2000-04-14 Macrolide anti-infectious agents
IL14577600A IL145776A0 (en) 1999-04-16 2000-04-14 Macrolide antiinfective agents
EP00925966A EP1171448A2 (en) 1999-04-16 2000-04-14 Macrolide antiinfective agents
AU44578/00A AU775637B2 (en) 1999-04-16 2000-04-14 Macrolide antiinfective agents

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US12972999P 1999-04-16 1999-04-16
US60/129,729 1999-04-16
US14017599P 1999-06-18 1999-06-18
US60/140,175 1999-06-18
US17215499P 1999-12-17 1999-12-17
US17215999P 1999-12-17 1999-12-17
US60/172,159 1999-12-17
US60/172,154 1999-12-17
US17380599P 1999-12-30 1999-12-30
US17380499P 1999-12-30 1999-12-30
US60/173,804 1999-12-30
US60/173,805 1999-12-30
US09/550,045 US6395710B1 (en) 1999-04-16 2000-04-14 Macrolide antiinfective agents

Publications (2)

Publication Number Publication Date
WO2000063225A2 WO2000063225A2 (en) 2000-10-26
WO2000063225A3 true WO2000063225A3 (en) 2001-01-18

Family

ID=27568857

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2000/009914 Ceased WO2000063224A2 (en) 1999-04-16 2000-04-14 Macrolide antiinfective agents
PCT/US2000/009915 Ceased WO2000063225A2 (en) 1999-04-16 2000-04-14 Macrolide antiinfective agents

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2000/009914 Ceased WO2000063224A2 (en) 1999-04-16 2000-04-14 Macrolide antiinfective agents

Country Status (16)

Country Link
US (3) US6395710B1 (en)
EP (1) EP1171446B1 (en)
JP (1) JP2003523938A (en)
KR (2) KR100710605B1 (en)
CN (1) CN1241931C (en)
AT (1) ATE340183T1 (en)
AU (2) AU775637B2 (en)
BR (1) BR0010680A (en)
CA (1) CA2369816A1 (en)
DE (1) DE60030847T2 (en)
ES (1) ES2272273T3 (en)
ID (1) ID30547A (en)
IL (2) IL145777A0 (en)
MX (1) MXPA01010524A (en)
NZ (1) NZ515027A (en)
WO (2) WO2000063224A2 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
CA2359708C (en) 1999-01-27 2005-10-25 Pfizer Products Inc. Ketolide antibiotics
US6590083B1 (en) * 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
EP1167376B1 (en) 2000-06-30 2004-07-14 Pfizer Products Inc. Macrolide antibiotics
US6472372B1 (en) 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
MXPA03008460A (en) * 2001-03-21 2004-06-30 Dow Agrosciences Llc Pesticidal spinosyn derivatives.
WO2003024986A1 (en) 2001-09-17 2003-03-27 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
AU2002346475A1 (en) 2001-12-05 2003-06-23 Ortho-Mcneil Pharmaceutical, Inc. 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials
US8063021B2 (en) * 2002-01-17 2011-11-22 Kosan Biosciences Incorporated Ketolide anti-infective compounds
SI1483251T1 (en) 2002-03-12 2010-03-31 Bristol Myers Squibb Co C3-cyano epothilone derivatives
US20040014691A1 (en) * 2002-04-25 2004-01-22 Searle Xenia Beebe 9-Oxime macrolide antibacterials
US20040009932A1 (en) * 2002-04-26 2004-01-15 Kathleen Phelan Antibacterial compounds with activity against penicillin-resistant streptococcus pneumoniae
CN1671726A (en) 2002-05-31 2005-09-21 詹森药业有限公司 3-descladine glycosyl-6-O-carbamoyl and 6-O-alkoxycarbonyl macrolide antibacterial drugs
US7427493B2 (en) 2002-06-28 2008-09-23 Kosan Biosciences Incorporated Recombinant genes for polyketide modifying enzymes
SI1532131T1 (en) * 2002-08-29 2009-04-30 Pfizer Motilide compounds
EP1638549A4 (en) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
US7407941B2 (en) * 2003-08-26 2008-08-05 Pfizer, Inc. N-desmethyl-N-substituted-11-deoxyerythromycin compounds
US20050113319A1 (en) * 2003-08-26 2005-05-26 Christopher Carreras 11-Deoxy-6,9-ether erythromycin compounds
AU2003304705A1 (en) * 2003-12-24 2005-08-03 Enanta Pharmaceuticals, Inc. 11-csubsituted erythromycin derivatives
UA85937C2 (en) * 2004-12-21 2009-03-10 Пфайзер Продактс Інк. Macrolide compounds
US7595300B2 (en) 2005-12-13 2009-09-29 Kosan Biosciences Incorporated 7-quinolyl ketolide antibacterial agents
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR THE PREPARATION OF MACROLIDE ANTIBACTERIAL AGENTS
CA2714389C (en) * 2008-02-08 2016-10-18 Basilea Pharmaceutica Ag Macrolides and uses of macrolides
JP5711135B2 (en) 2008-10-24 2015-04-30 センプラ ファーマシューティカルズ，インコーポレイテッド Methods for treating gastrointestinal disorders
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (en) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedures for the treatment of malaria, tuberculosis and MAC diseases
MX361413B (en) 2010-03-22 2018-12-05 Cempra Pharmaceuticals Inc Star Crystalline forms of a macrolide, and uses therefor.
CN102917708B (en) 2010-05-20 2015-11-25 森普拉制药公司 Process for preparing macrolides and ketolides and intermediates thereof
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc FLUOROCETOLIDES FORMING HYDROGEN LINKS TO TREAT DISEASES
JP5718488B2 (en) * 2011-03-01 2015-05-13 ウォックハート リミテッド Method for preparing ketolide intermediate
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
CN102718816B (en) * 2012-07-11 2014-11-05 山东大学 4''-O-(trans-beta-aryl allyl amide) formamyl azithromycin derivatives
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (en) 2013-03-15 2015-12-23 森普拉制药公司 Astringent method for preparing macrolide antibacterial agent
US12559514B2 (en) 2020-05-22 2026-02-24 Merck Sharp & Dohme Llc Synthesis of fluorinated nucleotides

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141926A (en) * 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
FR2754821A1 (en) * 1996-10-23 1998-04-24 Hoechst Marion Roussel Inc NOVEL DERIVATIVES OF ERYTHROMYCIN, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS
WO1999035157A1 (en) * 1998-01-02 1999-07-15 Pfizer Products Inc. Novel erythromycin derivatives

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
JP3259429B2 (en) * 1992-04-22 2002-02-25 大正製薬株式会社 5-O-desosaminylerythronolide A derivative
US5527780A (en) 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
US6066721A (en) 1995-07-06 2000-05-23 Stanford University Method to produce novel polyketides
US5672491A (en) 1993-09-20 1997-09-30 The Leland Stanford Junior University Recombinant production of novel polyketides
FR2718450B1 (en) * 1994-04-08 1997-01-10 Roussel Uclaf New erythromycin derivatives, their preparation process and their use as drugs.
FR2719587B1 (en) 1994-05-03 1996-07-12 Roussel Uclaf New erythromycin derivatives, their preparation process and their use as drugs.
ATE286133T1 (en) 1995-07-06 2005-01-15 Univ Leland Stanford Junior CELL-FREE SYNTHESIS OF POLYKETIDES
FR2739620B1 (en) * 1995-10-09 1997-12-19 Roussel Uclaf NOVEL DERIVATIVES OF 5-0-DESOSAMINYL 6-O-METHYL ERYTHRONOLIDE A, THEIR PREPARATION PROCESS AND THEIR APPLICATION TO THE PREPARATION OF BIOLOGICALLY ACTIVE PRODUCTS
US6274715B1 (en) 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
FR2742757B1 (en) * 1995-12-22 1998-01-30 Roussel Uclaf NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
DE69734678T2 (en) 1996-05-07 2006-08-17 Abbott Laboratories, Abbott Park 6-0 SUBSTITUTED ERYTHTHROMYCIN COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
FR2748746B1 (en) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc NEW PROCESS FOR ISOMERIZATION OF RADICAL METHYL IN 10 FROM ERYTHROMYCIN DERIVATIVES
ES2244001T3 (en) 1996-07-05 2005-12-01 Biotica Technology Limited Erythromycin and procedure for its preparation.
US6271255B1 (en) 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
FR2751656B1 (en) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
UA51730C2 (en) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-0-substituted ketolides having antibacterial activity
DE69733422T2 (en) * 1996-09-04 2006-05-04 Abbott Laboratories, Abbott Park 6-0-SUBSTITUTED KETOLIDES WITH ANTIBACTERIAL EFFECT
WO1998018808A1 (en) * 1996-10-31 1998-05-07 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
FR2757168B1 (en) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
CA2279259A1 (en) * 1997-02-04 1998-08-06 Abbott Laboratories Pain reducing parenteral liposome formulation
FR2760017B1 (en) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc NOVEL ERYTROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
EP0988308A1 (en) * 1997-06-11 2000-03-29 Pfizer Products Inc. 9-oxime erythromycin derivatives
BR9812577A (en) * 1997-09-30 2000-10-17 Abbott Lab Compound, process for preparing the same, pharmaceutical composition, and process for treating bacterial infections
US6124269A (en) 1997-10-29 2000-09-26 Abbott Laboratories 2-Halo-6-O-substituted ketolide derivatives
CO4990960A1 (en) * 1997-10-29 2000-12-26 Abbott Lab 2-HALO-6-O SUBSTITUTED CETOLIDE DERIVATIVES
ZA989830B (en) * 1997-10-29 1999-05-04 Taisho Pharmaceutical Co Ltd Erythromycin a derivatives
ATE275151T1 (en) 1998-03-03 2004-09-15 Pfizer Prod Inc 3,6-KETAL MACROLIDA ANTIBIOTIC
FR2777282B1 (en) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc NEW DERIVATIVES OF 2-FLUORO 3-DE ((2,6-DIDEOXY 3-C-METHYL 3-0-METHYL-ALPHA-L-RIBOHEXOPYRANOSYL) OXYL) 6-O-METHYL 3-OXO ERYTHROMYCIN, THEIR PREPARATION PROCESS AND THEIR APPLICATION TO THE SYNTHESIS OF ACTIVE INGREDIENTS OF MEDICINES
EP0952157B1 (en) * 1998-04-24 2003-06-18 Pfizer Products Inc. 9A, 11B-Dehydro derivatives of 9-oxime-3-keto-6-0-methylerythromycin
FR2781484B1 (en) * 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc NOVEL 6-DEOXY ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
JP2003512013A (en) 1998-10-29 2003-04-02 コーサン バイオサイエンシーズ， インコーポレイテッド Recombinant oleandride polyketide synthase
TR200101241T2 (en) 1998-11-03 2001-09-21 Pfizer Products Inc. New macrolide antibiotics
DE69933897T2 (en) 1998-12-10 2007-03-15 Pfizer Products Inc., Groton Carbamate and carbazate ketolide antibiotics
CA2359708C (en) * 1999-01-27 2005-10-25 Pfizer Products Inc. Ketolide antibiotics
KR20020008127A (en) * 1999-03-15 2002-01-29 스티븐 에프. 웨인스톡 6-O-substituted macrolides having antibacterial activity
CA2370743A1 (en) * 1999-04-16 2000-10-26 Dennis Hlasta Ketolide antibacterials
HUP0201516A3 (en) 1999-05-24 2003-03-28 Pfizer Prod Inc 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141926A (en) * 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
FR2754821A1 (en) * 1996-10-23 1998-04-24 Hoechst Marion Roussel Inc NOVEL DERIVATIVES OF ERYTHROMYCIN, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS
WO1999035157A1 (en) * 1998-01-02 1999-07-15 Pfizer Products Inc. Novel erythromycin derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J.M. WEBER ET AL.: "An erythromycin derivative produced by targeted gene disruption in Saccharopolyspora erythraea", SCIENCE, vol. 252, 1991, pages 114 - 117, XP002141603 *

Also Published As

Publication number Publication date
CA2369816A1 (en) 2000-10-26
WO2000063224A3 (en) 2001-01-18
WO2000063224A2 (en) 2000-10-26
ES2272273T3 (en) 2007-05-01
CN1241931C (en) 2006-02-15
EP1171446B1 (en) 2006-09-20
ID30547A (en) 2001-12-20
AU773678B2 (en) 2004-06-03
MXPA01010524A (en) 2002-03-14
CN1384838A (en) 2002-12-11
KR20020007372A (en) 2002-01-26
KR20020007374A (en) 2002-01-26
US6395710B1 (en) 2002-05-28
AU4237900A (en) 2000-11-02
EP1171446A2 (en) 2002-01-16
AU775637B2 (en) 2004-08-12
IL145777A (en) 2007-02-11
IL145777A0 (en) 2002-07-25
US6593302B2 (en) 2003-07-15
AU4457800A (en) 2000-11-02
KR100710605B1 (en) 2007-04-24
BR0010680A (en) 2002-02-19
DE60030847D1 (en) 2006-11-02
WO2000063225A2 (en) 2000-10-26
NZ515027A (en) 2004-01-30
US20020119938A1 (en) 2002-08-29
DE60030847T2 (en) 2007-04-19
ATE340183T1 (en) 2006-10-15
USRE39836E1 (en) 2007-09-11
JP2003523938A (en) 2003-08-12

Similar Documents

Publication Publication Date Title
WO2000063225A3 (en) Macrolide antiinfective agents
ZA95631B (en) Prolineamide derivatives
EP0908181B8 (en) Remedy for rosacea
CA2102591A1 (en) Hypoglycemic Agent
CA2433772A1 (en) Pyrimidine matrix metalloproteinase inhibitors
WO2001032652A3 (en) N-substituted carbamoyloxyalkyl-azolium derivatives
CA2149496A1 (en) 11,21-bisphenyl-19-norpregnane derivatives
WO2002082783A3 (en) Rotational mechanism for a wireless communication device
CA2024956A1 (en) Isoxazoles herbicides
MXPA03004192A (en) Use of cci-779 as an antineoplastic agent.
CA2039056A1 (en) 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
BR0008731A (en) 6-0-substituted macrolides, having antibacterial activity
EP1243268A4 (en) Medicinal composition
WO2003048134A1 (en) Triazole compound and medicinal use thereof
WO2001077090A3 (en) Isothiazole derivatives and their use as microbicides
WO2003024407A3 (en) Inhibitors of rnase p proteins as antibacterial compounds
CA2300069A1 (en) Naphthalimidobenzamide derivatives
EP1074545A4 (en) Isoquinolinesulfonamide derivatives and drugs containing the same as the active ingredient
CA2353205A1 (en) Agent for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient
HUP9901282A2 (en) Synergetic fungicide mixtures containing carbamate- and carboxylic acid amide derivatives as active ingredients and use thereof
NZ514791A (en) Erythromycin derivatives useful as antibiotics
MY104139A (en) Antimicrobial agent for animals
EP0761215A4 (en) Antibacterial agent
EE200200215A (en) Use of 2-amino-3,4-dihydroquinazolines for the preparation of a medicament for the treatment or prevention of diseases caused by ischemic conditions
TW200503718A (en) Pharmaceutical composition comprising a pyrrolopyridazine derivative

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 00809072.6

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2369886

Country of ref document: CA

Ref document number: 2369886

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: IN/PCT/2001/1038/KOL

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 514791

Country of ref document: NZ

ENP Entry into the national phase

Ref document number: 2000 612315

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/2001/010529

Country of ref document: MX

Ref document number: 1020017013225

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2000925966

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000925966

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020017013225

Country of ref document: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1020017013225

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 2000925966

Country of ref document: EP